Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology (Q33285375)

25 July 2017

Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology (English)

1 reference

25 July 2017

1 reference

1 reference

3

Tami Pilot-Matias

1 reference

25 July 2017

7

Rubina Mondal

1 reference

25 July 2017

13

Akhteruzzaman Molla

1 reference

25 July 2017

5

Gennadiy Koev

1 reference

25 July 2017

6

Preethi Krishnan

1 reference

25 July 2017

8

Ron Pithawalla

1 reference

25 July 2017

Teresa I Ng

1

1 reference

25 July 2017

Hongmei Mo

2

1 reference

25 July 2017

Yupeng He

4

1 reference

25 July 2017

Wenping He

9

1 reference

25 July 2017

Tanya Dekhtyar

10

1 reference

25 July 2017

Jeremy Packer

11

1 reference

25 July 2017

Mark Schurdak

12

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

25 July 2017

1 reference

25 July 2017

45

1 reference

25 July 2017

1413-1421

1 reference

25 July 2017

6

1 reference

Epidemiology of hepatitis C: geographic differences and temporal trends

25 July 2017

1 reference

7 January 2021

Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation

1 reference

7 January 2021

Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein

1 reference

7 January 2021

The Hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade

1 reference

7 January 2021

NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling

1 reference

7 January 2021

Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation

1 reference

7 January 2021

Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.

1 reference

7 January 2021

Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase

1 reference

7 January 2021

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

1 reference

7 January 2021

VX-950, a Novel Hepatitis C Virus (HCV) NS3-4A Protease Inhibitor, Exhibits Potent Antiviral Activities in HCV Replicon Cells

1 reference

7 January 2021

SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells

1 reference

7 January 2021

Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitro

1 reference

7 January 2021

The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture

1 reference

7 January 2021

In vitro studies of cross-resistance mutations against two hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061.

1 reference

7 January 2021

In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms

1 reference

7 January 2021

Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitro

1 reference

7 January 2021

Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034.

1 reference

7 January 2021

Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor. Reduced RNA replication fitness and partial rescue by second-site mutations

1 reference

7 January 2021

In vitro selected Con1 subgenomic replicons resistant to 2'-C-methyl-cytidine or to R1479 show lack of cross resistance

1 reference

7 January 2021

Selection and Characterization of Replicon Variants Dually Resistant to Thumb- and Palm-Binding Nonnucleoside Polymerase Inhibitors of the Hepatitis C Virus

1 reference

7 January 2021

Subgenomic hepatitis C virus replicons inducing expression of a secreted enzymatic reporter protein

1 reference

7 January 2021

Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture

1 reference

7 January 2021

Identification of a key determinant of hepatitis C virus cell culture adaptation in domain II of NS3 helicase

1 reference

7 January 2021

Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system

1 reference

7 January 2021

Interference of hepatitis C virus RNA replication by short interfering RNAs

1 reference

7 January 2021

Small Interfering RNA-Mediated Inhibition of Hepatitis C Virus Replication in the Human Hepatoma Cell Line Huh-7

1 reference

7 January 2021

Selection and characterization of varicella-zoster virus variants resistant to (R)-9-[4-hydroxy-2-(hydroxymethy)butyl]guanine

1 reference

7 January 2021

Screening for hepatitis C virus antiviral activity with a cell-based secreted alkaline phosphatase reporter replicon system

1 reference

7 January 2021

Activation of the interferon system by short-interfering RNAs

1 reference

7 January 2021

Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon

1 reference

7 January 2021

Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

1 reference

7 January 2021

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

1 reference

7 January 2021

Lymphotoxin and LIGHT signaling pathways and target genes

1 reference

7 January 2021

Hepatitis C virus NS5A-regulated gene expression and signaling revealed via microarray and comparative promoter analyses

1 reference

7 January 2021

Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease

1 reference

7 January 2021

Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor alpha-stimulated nuclear factor kappa B activation

1 reference

7 January 2021

Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor

1 reference

7 January 2021

Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor

1 reference

7 January 2021

Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT-3.

1 reference

7 January 2021

Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B.

1 reference

7 January 2021

Hepatitis C virus, ER stress, and oxidative stress

1 reference

7 January 2021

Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells

1 reference

7 January 2021

NF-kappaB as a primary regulator of the stress response

1 reference

7 January 2021

Hepatitis C virus NS5A: tales of a promiscuous protein

1 reference

7 January 2021

The role of Toll-like receptors in the host response to viruses

1 reference

7 January 2021

Convergence of the NF-kappaB and interferon signaling pathways in the regulation of antiviral defense and apoptosis

1 reference

7 January 2021

Calcium-dependent calpain proteases are implicated in processing of the hepatitis C virus NS5A protein

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21608

1 reference

release_5bx7rky4vbbelmfirntnhsd4p4

25 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5bx7rky4vbbelmfirntnhsd4p4

24 November 2022

mapped directly with Wikidata item

1 reference